Viewing Study NCT02349295


Ignite Creation Date: 2025-12-24 @ 1:53 PM
Ignite Modification Date: 2026-05-03 @ 8:39 AM
Study NCT ID: NCT02349295
Status: COMPLETED
Last Update Posted: 2020-07-01
First Post: 2014-10-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
Sponsor: Eli Lilly and Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 14310
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators